Quality of informed consent in cancer clinical trials: a cross-sectional survey
Steven Joffe(Children's Hospital of Philadelphia), Jane C. Weeks(King Edward Memorial Hospital), E. Francis Cook(Brigham and Women's Hospital), Paul D. Cleary(Yale University), Jeffrey W. Clark(Massachusetts General Hospital)
Cited by 659
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2014|2k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers
|Journal of Clinical Oncology|2012|1.6k